Software - Application
Compare Stocks
5 / 10Stock Comparison
DBD vs FISV vs FIS vs JKHY vs V
Revenue, margins, valuation, and 5-year total return — side by side.
Information Technology Services
Information Technology Services
Information Technology Services
Financial - Credit Services
DBD vs FISV vs FIS vs JKHY vs V — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Software - Application | Information Technology Services | Information Technology Services | Information Technology Services | Financial - Credit Services |
| Market Cap | $2.75B | $30.38B | $24.47B | $10.57B | $616.45B |
| Revenue (TTM) | $3.86B | $21.09B | $10.89B | $2.52B | $40.00B |
| Net Income (TTM) | $110M | $3.20B | $382M | $519M | $22.24B |
| Gross Margin | 26.0% | 60.8% | 38.1% | 44.1% | 80.4% |
| Operating Margin | 8.0% | 24.4% | 17.5% | 26.0% | 60.0% |
| Forward P/E | 14.4x | 7.0x | 7.5x | 21.8x | 24.6x |
| Total Debt | $1.17B | $29.12B | $4.01B | $0.00 | $25.17B |
| Cash & Equiv. | $387M | $798M | $599M | $102M | $20.15B |
DBD vs FISV vs FIS vs JKHY vs V — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Aug 23 | May 26 | Return |
|---|---|---|---|
| Diebold Nixdorf, In… (DBD) | 100 | 442.8 | +342.8% |
| Fiserv, Inc. (FISV) | 100 | 46.8 | -53.2% |
| Fidelity National I… (FIS) | 100 | 84.6 | -15.4% |
| Jack Henry & Associ… (JKHY) | 100 | 93.1 | -6.9% |
| Visa Inc. (V) | 100 | 130.8 | +30.8% |
Price return only. Dividends and distributions are not included.
Quick Verdict: DBD vs FISV vs FIS vs JKHY vs V
Each card shows where this stock fits in a portfolio — not just who wins on paper.
DBD is the #2 pick in this set and the best alternative if momentum is your priority.
- +79.3% vs FISV's -68.8%
FISV ranks third and is worth considering specifically for valuation efficiency.
- PEG 0.20 vs JKHY's 2.16
- Lower P/E (7.0x vs 24.6x), PEG 0.20 vs 1.55
FIS is the clearest fit if your priority is dividends.
- 3.5% yield, 1-year raise streak, vs JKHY's 1.5%, (2 stocks pay no dividend)
JKHY is the clearest fit if your priority is income & stability and growth exposure.
- Dividend streak 32 yrs, beta 0.28, yield 1.5%
- Rev growth 7.2%, EPS growth 19.3%, 3Y rev CAGR 6.9%
- Beta 0.28, yield 1.5%, current ratio 1.27x
- Beta 0.28 vs DBD's 1.21
V carries the broadest edge in this set and is the clearest fit for long-term compounding and sleep-well-at-night.
- 329.1% 10Y total return vs DBD's 289.1%
- Lower volatility, beta 0.68, Low D/E 66.4%, current ratio 1.08x
- 11.3% NII/revenue growth vs DBD's 1.5%
- 50.1% margin vs DBD's 2.8%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 11.3% NII/revenue growth vs DBD's 1.5% | |
| Value | Lower P/E (7.0x vs 24.6x), PEG 0.20 vs 1.55 | |
| Quality / Margins | 50.1% margin vs DBD's 2.8% | |
| Stability / Safety | Beta 0.28 vs DBD's 1.21 | |
| Dividends | 3.5% yield, 1-year raise streak, vs JKHY's 1.5%, (2 stocks pay no dividend) | |
| Momentum (1Y) | +79.3% vs FISV's -68.8% | |
| Efficiency (ROA) | 22.7% ROA vs FIS's 1.1%, ROIC 29.2% vs 6.0% |
DBD vs FISV vs FIS vs JKHY vs V — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
DBD vs FISV vs FIS vs JKHY vs V — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
V leads in 1 of 6 categories
FISV leads 1 • DBD leads 1 • FIS leads 0 • JKHY leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
V leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
V is the larger business by revenue, generating $40.0B annually — 15.9x JKHY's $2.5B. V is the more profitable business, keeping 50.1% of every revenue dollar as net income compared to DBD's 2.8%. On growth, JKHY holds the edge at +8.7% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $3.9B | $21.1B | $10.9B | $2.5B | $40.0B |
| EBITDAEarnings before interest/tax | $400M | $7.5B | $3.8B | $810M | $27.6B |
| Net IncomeAfter-tax profit | $110M | $3.2B | $382M | $519M | $22.2B |
| Free Cash FlowCash after capex | $266M | $4.0B | $2.8B | $728M | $21.2B |
| Gross MarginGross profit ÷ Revenue | +26.0% | +60.8% | +38.1% | +44.1% | +80.4% |
| Operating MarginEBIT ÷ Revenue | +8.0% | +24.4% | +17.5% | +26.0% | +60.0% |
| Net MarginNet income ÷ Revenue | +2.8% | +15.2% | +3.5% | +20.6% | +50.1% |
| FCF MarginFCF ÷ Revenue | +6.9% | +19.0% | +26.1% | +28.9% | +53.9% |
| Rev. Growth (YoY)Latest quarter vs prior year | +6.0% | -2.0% | +8.2% | +8.7% | — |
| EPS Growth (YoY)Latest quarter vs prior year | +163.6% | -29.1% | +92.3% | +12.5% | +35.3% |
Valuation Metrics
FISV leads this category, winning 6 of 7 comparable metrics.
Valuation Metrics
At 9.0x trailing earnings, FISV trades at a 86% valuation discount to FIS's 63.0x P/E. Adjusting for growth (PEG ratio), FISV offers better value at 0.25x vs FIS's 2.58x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $2.7B | $30.4B | $24.5B | $10.6B | $616.4B |
| Enterprise ValueMkt cap + debt − cash | $3.5B | $58.7B | $27.9B | $10.5B | $621.5B |
| Trailing P/EPrice ÷ TTM EPS | 31.05x | 8.96x | 63.00x | 23.40x | 31.50x |
| Forward P/EPrice ÷ next-FY EPS est. | 14.37x | 7.01x | 7.54x | 21.79x | 24.59x |
| PEG RatioP/E ÷ EPS growth rate | — | 0.25x | 2.58x | 2.32x | 1.99x |
| EV / EBITDAEnterprise value multiple | 7.64x | 6.63x | 7.66x | 13.53x | 24.65x |
| Price / SalesMarket cap ÷ Revenue | 0.72x | 1.43x | 2.29x | 4.45x | 15.41x |
| Price / BookPrice ÷ Book value/share | 2.66x | 1.21x | 1.76x | 5.01x | 16.66x |
| Price / FCFMarket cap ÷ FCF | 10.43x | 7.00x | 9.97x | 17.97x | 28.57x |
Profitability & Efficiency
Evenly matched — JKHY and V each lead in 4 of 9 comparable metrics.
Profitability & Efficiency
V delivers a 58.9% return on equity — every $100 of shareholder capital generates $59 in annual profit, vs $3 for FIS. FIS carries lower financial leverage with a 0.29x debt-to-equity ratio, signaling a more conservative balance sheet compared to FISV's 1.13x. On the Piotroski fundamental quality scale (0–9), DBD scores 6/9 vs V's 5/9, reflecting solid financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +10.1% | +12.4% | +2.7% | +24.0% | +58.9% |
| ROA (TTM)Return on assets | +2.9% | +4.0% | +1.1% | +17.0% | +22.7% |
| ROICReturn on invested capital | +14.0% | +8.1% | +6.0% | +21.0% | +29.2% |
| ROCEReturn on capital employed | +14.1% | +10.2% | +6.6% | +22.7% | +36.2% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 5 | 6 | 6 | 5 |
| Debt / EquityFinancial leverage | 1.06x | 1.13x | 0.29x | — | 0.66x |
| Net DebtTotal debt minus cash | $787M | $28.3B | $3.4B | -$102M | $5.0B |
| Cash & Equiv.Liquid assets | $387M | $798M | $599M | $102M | $20.2B |
| Total DebtShort + long-term debt | $1.2B | $29.1B | $4.0B | $0 | $25.2B |
| Interest CoverageEBIT ÷ Interest expense | 6.68x | 6.39x | 4.64x | 122.37x | 26.72x |
Total Returns (Dividends Reinvested)
DBD leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in DBD five years ago would be worth $38,342 today (with dividends reinvested), compared to $3,685 for FIS. Over the past 12 months, DBD leads with a +79.3% total return vs FISV's -68.8%. The 3-year compound annual growth rate (CAGR) favors DBD at 56.5% vs FISV's -22.0% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +23.3% | -13.4% | -27.3% | -17.8% | -7.1% |
| 1-Year ReturnPast 12 months | +79.3% | -68.8% | -35.3% | -13.6% | -7.4% |
| 3-Year ReturnCumulative with dividends | +283.4% | -52.5% | -6.6% | -1.0% | +41.2% |
| 5-Year ReturnCumulative with dividends | +283.4% | -51.7% | -63.2% | +0.3% | +42.6% |
| 10-Year ReturnCumulative with dividends | +289.1% | +9.7% | -13.2% | +94.9% | +329.1% |
| CAGR (3Y)Annualised 3-year return | +56.5% | -22.0% | -2.2% | -0.3% | +12.2% |
Risk & Volatility
Evenly matched — DBD and JKHY each lead in 1 of 2 comparable metrics.
Risk & Volatility
JKHY is the less volatile stock with a 0.28 beta — it tends to amplify market swings less than DBD's 1.21 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. DBD currently trades 88.6% from its 52-week high vs FISV's 29.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.21x | 0.94x | 0.76x | 0.28x | 0.68x |
| 52-Week HighHighest price in past year | $89.05 | $191.91 | $82.74 | $193.39 | $375.51 |
| 52-Week LowLowest price in past year | $43.61 | $52.91 | $43.30 | $141.81 | $293.89 |
| % of 52W HighCurrent price vs 52-week peak | +88.6% | +29.6% | +57.1% | +75.5% | +85.6% |
| RSI (14)Momentum oscillator 0–100 | 47.4 | 36.5 | 43.3 | 28.2 | 53.3 |
| Avg Volume (50D)Average daily shares traded | 460K | 5.3M | 5.5M | 902K | 6.9M |
Analyst Outlook
Evenly matched — FIS and JKHY each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: DBD as "Buy", FISV as "Buy", FIS as "Buy", JKHY as "Buy", V as "Buy". Consensus price targets imply 42.6% upside for FIS (target: $67) vs 12.8% for V (target: $362). For income investors, FIS offers the higher dividend yield at 3.45% vs V's 0.73%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | $100.00 | $74.64 | $67.38 | $203.75 | $362.45 |
| # AnalystsCovering analysts | 13 | 60 | 37 | 22 | 61 |
| Dividend YieldAnnual dividend ÷ price | — | — | +3.5% | +1.5% | +0.7% |
| Dividend StreakConsecutive years of raises | 0 | — | 1 | 32 | 15 |
| Dividend / ShareAnnual DPS | — | — | $1.63 | $2.25 | $2.36 |
| Buyback YieldShare repurchases ÷ mkt cap | +4.8% | +19.4% | 0.0% | +0.3% | +2.2% |
V leads in 1 of 6 categories (Income & Cash Flow). FISV leads in 1 (Valuation Metrics). 3 tied.
DBD vs FISV vs FIS vs JKHY vs V: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is DBD or FISV or FIS or JKHY or V a better buy right now?
For growth investors, Visa Inc.
(V) is the stronger pick with 11. 3% revenue growth year-over-year, versus 1. 5% for Diebold Nixdorf, Incorporated (DBD). Fiserv, Inc. (FISV) offers the better valuation at 9. 0x trailing P/E (7. 0x forward), making it the more compelling value choice. Analysts rate Diebold Nixdorf, Incorporated (DBD) a "Buy" — based on 13 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — DBD or FISV or FIS or JKHY or V?
On trailing P/E, Fiserv, Inc.
(FISV) is the cheapest at 9. 0x versus Fidelity National Information Services, Inc. at 63. 0x. On forward P/E, Fiserv, Inc. is actually cheaper at 7. 0x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Fiserv, Inc. wins at 0. 20x versus Jack Henry & Associates, Inc. 's 2. 16x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — DBD or FISV or FIS or JKHY or V?
Over the past 5 years, Diebold Nixdorf, Incorporated (DBD) delivered a total return of +283.
4%, compared to -63. 2% for Fidelity National Information Services, Inc. (FIS). Over 10 years, the gap is even starker: V returned +329. 1% versus FIS's -13. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — DBD or FISV or FIS or JKHY or V?
By beta (market sensitivity over 5 years), Jack Henry & Associates, Inc.
(JKHY) is the lower-risk stock at 0. 28β versus Diebold Nixdorf, Incorporated's 1. 21β — meaning DBD is approximately 328% more volatile than JKHY relative to the S&P 500. On balance sheet safety, Fidelity National Information Services, Inc. (FIS) carries a lower debt/equity ratio of 29% versus 113% for Fiserv, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — DBD or FISV or FIS or JKHY or V?
By revenue growth (latest reported year), Visa Inc.
(V) is pulling ahead at 11. 3% versus 1. 5% for Diebold Nixdorf, Incorporated (DBD). On earnings-per-share growth, the picture is similar: Diebold Nixdorf, Incorporated grew EPS 677. 3% year-over-year, compared to -47. 2% for Fidelity National Information Services, Inc.. Over a 3-year CAGR, JKHY leads at 6. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — DBD or FISV or FIS or JKHY or V?
Visa Inc.
(V) is the more profitable company, earning 50. 1% net margin versus 2. 5% for Diebold Nixdorf, Incorporated — meaning it keeps 50. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: V leads at 60. 0% versus 8. 8% for DBD. At the gross margin level — before operating expenses — V leads at 80. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is DBD or FISV or FIS or JKHY or V more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Fiserv, Inc. (FISV) is the more undervalued stock at a PEG of 0. 20x versus Jack Henry & Associates, Inc. 's 2. 16x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Fiserv, Inc. (FISV) trades at 7. 0x forward P/E versus 24. 6x for Visa Inc. — 17. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for FIS: 42. 6% to $67. 38.
08Which pays a better dividend — DBD or FISV or FIS or JKHY or V?
In this comparison, FIS (3.
5% yield), JKHY (1. 5% yield), V (0. 7% yield) pay a dividend. DBD, FISV do not pay a meaningful dividend and should not be held primarily for income.
09Is DBD or FISV or FIS or JKHY or V better for a retirement portfolio?
For long-horizon retirement investors, Jack Henry & Associates, Inc.
(JKHY) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 28), 1. 5% yield). Both have compounded well over 10 years (JKHY: +94. 9%, DBD: +289. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between DBD and FISV and FIS and JKHY and V?
These companies operate in different sectors (DBD (Technology) and FISV (Technology) and FIS (Technology) and JKHY (Technology) and V (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: DBD is a small-cap quality compounder stock; FISV is a mid-cap deep-value stock; FIS is a mid-cap income-oriented stock; JKHY is a mid-cap quality compounder stock; V is a large-cap quality compounder stock. FIS, JKHY, V pay a dividend while DBD, FISV do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.